The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The DASH Study: A phase 1b study of dalantercept plus sorafenib in advanced hepatocellular carcinoma.
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Aduro Biotech (I); Astellas Pharma; AstraZeneca (I); Celgene; Celsion; cipla; Exelixis; IntegraGen; Jennerex; Lilly/ImClone; MedImmune; Novartis; Pharmacyclics (I); Sanofi (I); Silenseed (I); Vicus Therapeutics
Research Funding - Abbott Laboratories (Inst); Amgen (Inst); Bayer (Inst); Exelixis (Inst); Genentech (Inst); Lilly/ImClone (Inst); Novartis (Inst); Polaris (Inst); Roche (Inst); Vicus Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris
 
Rebecca A. Miksad
Consulting or Advisory Role - Acceleron Pharma; Onyx; OptumInsight
Research Funding - Acceleron Pharma (Inst); ArQule (Inst); Bayer/Onyx (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Newlink Genetics (Inst)
 
Martin Gutierrez
No Relationships to Disclose
 
Mohamedtaki Abdulaziz Tejani
No Relationships to Disclose
 
Manish Sharma
No Relationships to Disclose
 
Weijing Sun
No Relationships to Disclose
 
Charles A. Henderson
No Relationships to Disclose
 
Ari David Baron
Speakers' Bureau - Bristol-Myers Squibb; Genentech
 
Olugbenga Olanrele Olowokure
No Relationships to Disclose
 
R. Scott Pearsall
Employment - Acceleron Pharma
Stock and Other Ownership Interests - Acceleron Pharma
 
Dawn Wilson
Employment - Acceleron Pharma
Stock and Other Ownership Interests - Acceleron Pharma
 
Chris Korth
Employment - Acceleron Pharma
Stock and Other Ownership Interests - Acceleron Pharma
 
Matthew L. Sherman
Employment - Acceleron Pharma
Leadership - Acceleron Pharma
Stock and Other Ownership Interests - Acceleron Pharma
 
Shuchi Sumant Pandya
Employment - Acceleron Pharma
Stock and Other Ownership Interests - Acceleron Pharma